After 17 years involvement with the company, former Chemeq chairman Graham Melrose has announced his intention to retire from the board.
After 17 years involvement with the company, former Chemeq chairman Graham Melrose has announced his intention to retire from the board.
Dr Melrose, the company's founding chairman, stepped down as non-executive chairman of the company he founded in January this year.
Chemeq has had a tumultuous past two years, lurching through a series of bad news events which initially attracted the ire of investors and later caught the eye of regulators.
A statement from the company is pasted below
Chemeq Limited announces that Dr Graham Melrose, founder of Chemeq, has advised the Company today that he wishes to retire as a non-executive director of Chemeq with immediate effect.
Dr Graham Melrose said it was a bittersweet day for him but it was time for him to retire from the Board.
"I am proud to have been involved with Chemeq since it was founded in 1989, but it is now time for me to move on," Dr Melrose said.
Chairman John Hopkins said that Chemeq owed its existence to the vision and commitment of Dr Melrose.
"Graham has done a simply outstanding job building this business over the last 17 years, and on behalf of the Board and all Chemeq staff members, I would like to thank him for his dedicated service to Chemeq," Mr Hopkins said.
"All of us at Chemeq wish Graham and his family all the very best for the future."
"It has been a great privilege and honour to lead Chemeq, and I am pleased that the Company is now in the committed hands of a new Board and management team led by John Hopkins and David Williams." Dr Melrose said.
"I would like to take this opportunity to personally thank Chemeq's shareholders, particularly the long-term shareholders, who have supported the Company over a long period and continue to believe in the future of Chemeq."
"I believe Chemeq has a world class product with enormous market potential at a time when the world is becoming increasingly concerned with the spread of antibiotic resistant super-bugs."
"I continue to believe in the long-term potential of Chemeq and I will be following the Company's fortunes with interest in the future."
